Wegovy Side Effects Guide
Wegovy side effects: what the 2.4 mg dose really brings
~44%
Nausea (STEP 1)
~30%
Diarrhea
~24%
Vomiting
Wegovy is semaglutide dosed for weight management: the ladder climbs over about 16 weeks to 2.4 mg weekly, the highest approved semaglutide dose. Same molecule as Ozempic, higher target, and the side-effect numbers scale accordingly: in the STEP 1 trial, around 44% reported nausea, 30% diarrhea, 24% vomiting, and 23% constipation. Almost all of it was mild to moderate, clustered around dose increases, and settled with adaptation; fewer than 5% left the trial over GI effects. The red flags are the class standards: severe persistent abdominal pain, vomiting past 24 hours, and yellowing of skin or eyes.
Highlights
Key takeaways
- 01
Wegovy's side-effect list is Ozempic's list at higher rates, because the dose is higher. Nausea ~44%, diarrhea ~30%, vomiting ~24%, constipation ~23% in STEP 1, mostly mild to moderate.
- 02
The 16-week titration (0.25 to 2.4 mg in five steps) exists to spread the adaptation out. Each step briefly replays the early adjustment; the last two steps are where most people feel it most.
- 03
Effects cluster in the 24 to 72 hours after the weekly shot and settle within 4 to 8 weeks per dose level.
- 04
Holding a step longer is routine and legitimate. The maintenance dose you can live with beats the maximum dose you cannot.
- 05
Fewer than 1 in 20 trial participants stopped over GI effects. Food mechanics, fluids, and pacing manage most weeks.
- 06
Log symptom, severity, and date next to each shot: the fading-or-building trend is what your prescriber actually needs for the next titration call.
Wegovy side effects: prevalence, onset, duration
| Symptom | Prevalence (STEP 1) | Onset | Peaks | Resolves by | Red flag |
|---|---|---|---|---|---|
| Nausea | ~44% | Days 1–3 after a dose | Dose step-ups, esp. 1.7→2.4 mg | Weeks 4–8 per level | Can't keep fluids down |
| Diarrhea | ~30% | Days 1–5 | Weeks 1–2 of a new level | Weeks 4–6 | Bloody, or dehydration signs |
| Vomiting | ~24% | Days 1–3 | Dose step-ups | By week 6 | Lasts over 24 hours |
| Constipation | ~23% | Week 1 onward | Weeks 2–6 | Ongoing, manage | Severe pain, distension |
| Abdominal pain | ~20% | Variable | Early weeks | Variable | Severe, radiating to back |
| Headache / fatigue | ~11–15% | Days 1–5 | Weeks 1–4 | Weeks 6–8 | Fainting |
Rates from the STEP 1 trial of semaglutide 2.4 mg (placebo arms reported far lower rates); they are general educational figures, not predictions for you. Onset and resolution windows are approximate. Confirm anything that matters with your clinician.
Why are Wegovy's numbers higher than Ozempic's?
Wegovy and Ozempic are the same molecule, semaglutide, made by the same company. The difference is the target dose: Ozempic tops out at 2 mg for diabetes, Wegovy climbs to 2.4 mg for weight management. More semaglutide means a stronger appetite effect and a more slowed stomach, and the side-effect rates scale with it.
The character of the effects does not change: the same nausea-led GI list, the same clustering after dose days, the same fade with adaptation. If you have read our Ozempic guide, everything there applies here at slightly higher volume.
When do side effects hit, and how long do they last?
The weekly rhythm rules: most people feel the medication most in the day or two after the shot and best by mid-week. Within each dose level, the roughest stretch is the first two to three weeks, settling by weeks 4 to 8 as levels plateau.
Because Wegovy's ladder is long, the pattern repeats at each of the five steps. Most people find later steps gentler than the numbers suggest, because the gut has already met the drug; the jump to the final 2.4 mg step is the most commonly reported exception.
The dose ladder, and where it gets rough
The standard schedule steps monthly: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, then 2.4 mg maintenance, roughly 16 weeks in total. Every step exists to buy the gut adaptation time.
Two practical notes. First, holding a step an extra month when a jump is rough is standard practice, not failure; plenty of people also maintain on 1.7 mg when 2.4 mg does not suit them. Second, the week after each increase is your highest-information week: log it properly and the next titration conversation makes itself.
Which Wegovy side effects are serious red flags?
The serious list is the semaglutide class list. Severe, persistent stomach pain, especially radiating to the back or paired with unrelenting vomiting, can signal pancreatitis and needs same-day care. Sharp right-sided pain after fatty meals points at the gallbladder; rapid weight loss raises gallstone risk by itself.
Vomiting past 24 hours risks dehydration and kidney strain. Combined with insulin or a sulfonylurea, low blood sugar becomes possible: shakiness, sweating, confusion. And the class carries the rodent-study thyroid C-cell warning: not for anyone with personal or family history of medullary thyroid carcinoma or MEN2.
Call your doctor right away if you notice
- Severe stomach pain that won't go away, especially radiating to the back
- Vomiting lasting more than 24 hours, or fluids not staying down
- Yellowing of the skin or eyes
- Sharp right-sided pain after fatty meals, or pain with fever
- Very little urine, dizziness, or a racing heart
- Shakiness, sweating, or confusion if you also take insulin or a sulfonylurea
- A new neck lump, hoarseness, or trouble swallowing
- Trouble breathing, or rash with swelling of the face or tongue
What makes the weeks easier?
Everything in our nausea and food guides applies at full strength here, since Wegovy runs the strongest semaglutide dose. The compact version:
- Small, slow, protein-first meals; stop at pleasantly done.
- Low-fat and bland for the 2 to 3 days after each shot.
- Cold foods over hot when smells trigger you.
- 2 to 3 liters of fluid in small sips across the day.
- Plan lighter social and training days right after dose day.
- Ask your prescriber about holding a step if a jump stays rough past two weeks.
Missed doses and stopping
One late dose is buffered by semaglutide's 7-day half-life: the label allows catch-up within 5 days, otherwise skip and resume on schedule, never double. After several missed weeks, call your prescriber; restarting often means stepping back down the ladder.
If you stop entirely, GI effects fade over weeks as the drug clears, and appetite returns behind them, often louder for a while. Regain risk is real and front-loaded; our guide on life after stopping covers what protects the result.
FAQ
Frequently asked questions
What are the most common Wegovy side effects?
In STEP 1: nausea (~44%), diarrhea (~30%), vomiting (~24%), constipation (~23%), plus abdominal discomfort, headache, and early fatigue. The large majority were mild to moderate and clustered around dose increases; under 5% stopped over GI effects.
How long do Wegovy side effects last?
Effects cluster in the 24 to 72 hours after the weekly shot and settle within about 4 to 8 weeks at each dose level. Each step up the 16-week ladder briefly replays a milder version of the adjustment.
Is Wegovy harder to tolerate than Ozempic?
Same molecule, higher target dose, so trial GI rates run higher. The character and management are identical, and the slower, longer titration exists precisely to spread the adaptation out. Many people maintain on 1.7 mg when 2.4 mg does not suit them.
When should I call a doctor about Wegovy side effects?
Same-day: severe persistent abdominal pain (especially radiating to the back), vomiting past 24 hours, yellowing of skin or eyes, dehydration signs, or possible low blood sugar if you take insulin or a sulfonylurea. Building-but-not-severe symptoms belong at your next appointment, with your log.
Track your Wegovy journey on one quiet line.
Log your shot, injection site, meals, and side-effect severity together, and walk into your next appointment with a week-by-week picture instead of a guess.
Sources
- 1.Wegovy (semaglutide 2.4 mg) prescribing information: adverse reactions, warnings, and dosage sections. View label on DailyMed ↗
- 2.Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021. Read on NEJM ↗
- 3.STEP clinical program summaries: gastrointestinal adverse events and discontinuation rates. Find on PubMed ↗
- 4.Published reviews of semaglutide tolerability and GI side-effect management. Find on PubMed ↗
This guide is for general education and is not medical advice. It doesn't account for your personal medical history, other medications, or your individual situation, and it doesn't replace a conversation with your doctor or pharmacist. Do not start, stop, or change the dose of Wegovy or any medication based on what you read here. If you think you have a medical emergency, call your local emergency number. DoseLog is a tracking app; drug and company names are used factually under nominative fair use, and DoseLog is not affiliated with, endorsed by, or sponsored by any manufacturer mentioned.
Keep reading
GLP-1 Side Effects Overview
GLP-1 side effects: the complete plain-language overview
Ozempic Side Effects Guide
Ozempic side effects: what to expect on the weekly semaglutide shot
Zepbound Side Effects Guide
Zepbound side effects: what to expect on weekly tirzepatide
Mounjaro Side Effects Guide
Mounjaro side effects: the practical guide for weekly tirzepatide